School of Medicine | Biomedical Graduate Education
Tumor Biology Program
Tumor Biology Program
phd student doing research

Leading the Fight Against Cancer

We equip students with the interdisciplinary education, laboratory experience and career skills they’ll need to excel in cancer research.

M.S. Info Sessions


The past two decades have seen a revolution in the study of cancer biology. Advances in molecular biology, biochemistry and cell biology have contributed to our understanding of malignant transformation, cancer prevention and cancer therapy. The Georgetown University Interdisciplinary Program in Tumor Biology provides doctoral and master’s students with an excellent academic environment and interdisciplinary training for a career in cancer biology research. Our students develop their potential to produce highest-quality research and academic scholarship.

Fall 2026 M.S. Admissions

master's student doing research

Early Application with Fee Waiver: January 15
Priority Application: May 15
Final Deadline: July 1

Admissions InformationRSVP for an Info SessionRequest More InformationApply Online

The Georgetown Difference

Expert Faculty

Learn from respected scientists who are leaders in the field of cancer research.

Ideal Location

Students have access to federal agencies and biohealth companies around Washington, D.C.

Career Services

One-on-one advising and professional development opportunities prepare students for success.

Our program brings together about 60 faculty members from basic science and clinical departments, as well as the expertise and resources of Georgetown’s Lombardi Comprehensive Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center that combines excellence in basic and clinical cancer research, as well as research on cancer control and prevention.

A combination of formal courses, seminars, and ongoing collaborative research projects bring together faculty and trainees in a unified doctoral program committed to providing quality education in cancer biology, prevention, and therapy.

A chart of MS-TBIO alumni 2016-2021 with known employment or degree destinations, identified via surveys and/or web search. Of 39 alumni, 77% were employed: 31% in Healthcare, 15% in BioPharma, 10% in Academia, 10% in Government/Policy, 5% in Consulting, 5% Other. 23% were pursuing advanced degrees: 15% Ph.D., 8% M.D.

Alumni Success

Coursework, lab experience, mentorship and career development resources all empower our students to pursue impactful careers.

M.S. Alumni Outcomes M.S. and Ph.D. Career Services

News

More TBIO News

Announcements

Tumor Biology Researchers Chosen for Toulmin Pilot Projects Funding in 2026

Tumor Biology faculty Michael D. Johnson and Aykut Üren will be among the recipients of GUMC’s Toulmin Pilot Projects funding for the coming year. The awards support innovative research projects that have significant potential to attract additional funding in this competitive research environment.

July 11, 2025

Announcements

New Blood Test Holds Potential to Reduce Liver Transplant Failures

Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other complications. Now, a new study by scientists from Georgetown University and MedStar Health describes how a single blood sample can be used to catch problems at the earliest stages, allowing tailored treatment to prevent the organ’s failure.

June 27, 2025

Clear glass awards inscribed with honorees' names sit on a table at the Office of Technology Commercialization's 2025 Research and Innovation Showcase

Announcements

Georgetown Office of Technology Commercialization Recognizes BGE Faculty’s Innovations

BGE-affiliated honorees for 2025 included oncology and pharmacology professor Anton Wellstein (Innovator of the Year Award) and oncology and medicine professor Marc Lippman (Partnership Award).

April 22, 2025